Kazuki Oishi Selected Research

stage-specific embryonic antigen-3 (GL-X)

12/2017

Possibility of inhibiting arthritis and joint destruction by SSEA-3 positive cells derived from synovial tissue in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuki Oishi Research Topics

Disease

3	Infections 01/2021 - 11/2015
1	Rheumatoid Arthritis 12/2017
1	Arthritis (Polyarthritis) 12/2017
1	Neoplasms (Cancer) 07/2016
1	Mucolipidoses (Sialidosis) 01/2016
1	Neuraminidase deficiency with beta-galactosidase deficiency 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2015

Drug/Important Bio-Agent (IBA)

3	Neuraminidase (Sialidase)IBA 11/2019 - 11/2015
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2019 - 11/2015
1	Glucosylceramides (Glucocerebrosides)IBA 01/2021
1	CyclodextrinsIBA 01/2021
1	LipidsIBA 01/2021
1	GlycosphingolipidsIBA 01/2021
1	CDw17 antigen (lactosylceramide)IBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 12/2017
1	CollagenIBA 12/2017
1	stage-specific embryonic antigen-3 (GL-X)IBA 12/2017
1	GlycoconjugatesIBA 07/2016
1	G(M3) GangliosideIBA 07/2016
1	GangliosidesIBA 07/2016
1	naringinIBA 07/2016
1	GlycolipidsIBA 07/2016
1	Glycoproteins (Glycoprotein)IBA 11/2015
1	Mannose (D-Mannose)IBA 11/2015